Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Epidemiology. 2019 Nov;30(6):845–852. doi: 10.1097/EDE.0000000000001078

TABLE 2.

Associations between douching, talc use, and uterine cancer in the Sister Study

Full cohort, N(%) Uterine cancer cases, N(%) Adjusted Hazard Ratiob
N=33,609a N=271a

Douching
Ever
No 28,459 (85) 231 (86) 1.0
Yes 4,896 (15) 37 (14) 1.0 (0.72, 1.5)
Frequencyc
None 28,459 (85) 231 (86) 1.0
Sometimes 3,969 (12) 31 (12) 1.1 (0.73, 1.5)
Frequently 927 (2.8) 6 (2.2) 0.86 (0.37, 2.0)
p-trend= 0.96
Ever in past 12 months
No 29,139 (87) 234 (88) 1.0
Yes 4,201 (13) 33 (12) 1.1 (0.75, 1.6)
Ever, ages 10–13
No 32,183 (97) 259 (98) 1.0
Yes 961 (2.9) 5 (1.9) 0.67 (0.28, 1.6)d
Talc use
Ever
No 24,250 (74) 178 (66) 1.0
Yes 8,686 (26) 90 (34) 1.2 (0.94, 1.6)
Frequencyc
None 24,250 (74) 178 (66) 1.0
Sometimes 5,610 (17) 51 (19) 1.1 (0.81, 1.5)
Frequently 3,076 (9.3) 39 (15) 1.4 (0.99, 2.0)
p-trend= 0.07
Ever in past 12 months
No 28,299 (86) 221 (82) 1.0
Yes 4,625 (14) 47 (18) 1.1 (0.82, 1.6)
Ever, ages 10–13
No 25,940 (82) 198 (77) 1.0
Yes 5,847 (18) 59 (23) 1.2 (0.90, 1.6)d
Long-term use (age 10–13 and last 12 months)
No 29,989 (94) 244 (94) 1.0
Yes 1,786 (5.6) 16 (6.2) 1.1 (0.65, 1.8)d
Combined use
Ever
Neither 21,344 (65) 159 (60) 1.0
Both 1,840 (5.6) 18 (6.8) 1.3 (0.79, 2.1)
Talc/no douching 6,715 (21) 20 (26) 1.2 (0.90, 1.6)
Douching/no talc 2,783 (8.5) 18 (6.8) 0.98 (0.60, 1.6)
Ever in past 12 months
Neither 25,023 (77) 195 (74) 1.0
Both 968 (3.0) 9 (3.4) 1.2 (0.64, 2.4)
Talc/no douching 3,586 (11) 37 (14) 1.1 (0.79, 1.6)
Douching/no talc 3,082 (9.4) 23 (8.7) 1.1 (0.68, 1.7)

Missing: Ever douching and douching frequency (254 from cohort, including 3 cases), douching last 12 months (269 from cohort, including 4 cases), douching age 10–13 (465 from cohort, including 4 cases), ever talc use and talc use frequency (673 from cohort, including 3 cases), talc last 12 months (685 from cohort, including 3 cases), talc use ages 10–13 (1,822 in cohort, including 11 cases), long-term talc use (1,834 in cohort, including 11 cases), both ever (927 in cohort, including 6 cases), both in last 12 months (950 in cohort, including 7 cases)

a

Participants with complete confounder information.

b

Adjusted for race/ethnicity, education, body mass index (restricted cubic spline), menopausal status, parity, duration of oral contraceptive use, hormone therapy use, smoking, alcohol use, and age at menarche.

c

Sometimes users used <1/month in the last year or “sometimes” ages 10–13, regular users used ≥1/month in the last year or “frequently” ages 10–13

d

Adjusted for race/ethnicity, age at menarche and relative weight at age 10 only, had to be non-missing for other covariates